Takeaway

• A once-weekly dose of tirzepatide 5 mg, 10 mg, or 15 mg demonstrated substantial and sustained body weight reduction in adults who were overweight or obese and did not have diabetes.
• Tirzepatide also improved several prespecified cardiometabolic risk factors and the quality of life (QoL).
• Gastrointestinal events of mostly...